# US 2010/0136614 A1 · Dendrimer-like modular delivery vector

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0136614 A1
- Document ID: US20100136614A1
- Status: Published application
- Kind: A1
- Application number: 11/583,990
- Filed: 2006-10-18
- Published: 2010-06-03
- Earliest claimed: 2005-10-18
- Inventors: Dan Luo; Yougen Li
- Web page: https://patentgrep.com/patent/US20100136614A1

## CPC

- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/12: Antihypertensives
- A61P 21/02: Muscle relaxants, e.g. for tetanus or cramps
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/20: Hypnotics; Sedatives
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/10: Antimycotics
- A61P 31/12: Antivirals
- A61P 31/18: for HIV
- A61P 33/00: Antiparasitic agents
- A61P 33/02: Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P 35/00: Antineoplastic agents
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- C08G 83/003: {Dendrimers}
- C12N 11/18: Multi-enzyme systems
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 2310/52: branched
- C12N 2320/32: Special delivery means, e.g. tissue-specific
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. The nucleic acids are used to form dendrimers that are useful as supports, vectors, carriers or delivery vehicles for a variety of compounds in biomedical and biotechnological applications. In particular, the macromolecules may be used for the delivery of drugs, genetic material, imaging components or other functional molecule to which they can be conjugated. An additional feature of the macromolecules is their ability to be targeted for certain organs, tumors, or types of tissues. Methods of utilizing such biomaterials include delivery of functional molecules to cells.

## Claims

### Claim 1

A composition comprising a protein manufacturing gel comprising a polymer matrix, said matrix having at least a portion thereof formed with a plurality of nucleic acid molecules.

### Claim 2

A composition comprising as DNA hydrogel for protein expression comprising a polymer matrix and a nucleic acid molecule encoding said protein.

### Claim 3

A composition comprising a DNA hydrogel for protein expression comprising nucleic acid molecules that form a three-dimensional matrix.

### Claim 4

A composition comprising a protein manufacturing hydrogel comprising a polymer matrix formed of a DNA hydrogel, wherein a nucleic acid molecule is linked to at least a portion of the polymer matrix, whereby said nucleic acid molecule encodes a protein to be expressed.

### Claim 5

A composition comprising as hydrogel. comprising a three-dimensional matrix, wherein said matrix effects expression of as protein at A level Of at least 1 mg per cm3 of said matrix.

### Claim 6 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said matrix produces said protein at a level of at least 500 μg per 1 μg of nucleic acid molecules.

### Claim 7 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said matrix comprises pores.

### Claim 8 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said matrix comprises a component selected from a group consisting of poly(N-isopropylacrylamide), poly(N-alkylacrylamide), poly(N-n-propylacrylamide), poly(N-isopropylmethacrylamide), polyethylene oxide)-poly(propylene oxide)-poly(ethylene oxide), poly(DTEC), dextran-polylactide, elastin-like polypeptides, a polyester, polylactide, poly(L.-lactic acid), poly(D,L,-lactic acid), poly(lactide-co-glycolides), biotinylated poly(ethylene glycol-block-lactic acid), poly(alkylcyanoacrylate), poly(epsilon-caprolactone), polyanhydride, poly(bis(p-carboxyphenoxy) propane-sebacic acid), polyorthoester, polyphosphoester, polyphosphazene, polystyrene, polyurethane, poly(amino acid), and a derivative of any thereof.

### Claim 9 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said matrix comprises nucleic acid molecule that comprise DNA having a total concentration of about 0.005, 0.0025, 0.01, 0.02, 0.03, 0.04, 0.05, 0.00, 0.07, 0.08, 0.09 or 0.10 mM.

### Claim 10 (depends on 7)

The composition of claim 7, wherein said pores are from about 50 rim to 500 nm in size.

### Claim 11 (depends on 7)

The composition of claim 7, wherein said pores have a size selected from a group consisting of about 5 nm, about 10 nm, about 15 nm, about 20 nm, about 30 nm, about 40 nm, about 50 nm, and about 100 rim.

### Claim 12

A method for in vitro syntheses of one or more proteins, comprising expressing one or more proteins from a protein manufacturing hydrogel.

### Claim 13

A method for cell-free syntheses of one or snore proteins comprising expressing one or more proteins from a matrix comprising a plurality of branched nucleic acid monomers.

### Claim 14

A method for cell-free synthesis of one or more proteins comprising expressing one or more proteins from a DNA hydrogel.

### Claim 15

A kit comprising a DNA hydrogel and macromolecules necessary for protein expression.

### Claim 16

A kit comprising X-shape DNA, ligase and macromolecules necessary for protein expression.

### Claim 17

A method of producing a protein manufacturing gel comprising, forming a polymer matrix, said matrix having at least as portion thereof formed with a plurality of nucleic acid molecules.

### Claim 18 (depends on 17)

The method of claim 17, wherein said matrix is comprised of nucleic acid molecules that have X-, Y-, T-, dumbbell, dendrimer-shape, or a combination thereof.

### Claim 19 (depends on 17)

The method of claim 17, wherein said nucleic acid molecules are X-shape.

### Claim 20 (depends on 17)

The method of claim 17, wherein said nucleic acid molecules are Y-shape.

### Claim 21 (depends on 17)

The method of claim 17, wherein said nucleic acid molecules comprise DNA and/or RNA.

### Claim 22 (depends on 17)

The method of claim 17, wherein said nucleic acid molecules are linked to each other covalently and/or non-covalently.

### Claim 23 (depends on 17)

The method of claim 17, wherein said matrix is further comprised of a plurality of peptide molecules that function as structural support.

### Claim 24

A method of producing proteins comprising, expressing one or more proteins from a hydrogel that comprises coding and non-coding nucleic acid molecules.

### Claim 25

A method of producing modified proteins comprising, expressing. one or more proteins from a hydrogel that comprises nucleic acid molecules and one or more macromolecules necessary for protein modification, thus producing modified proteins.

### Claim 26 (depends on 25)

The method of claim 25, wherein said modifications include phosphorylation, glycosylation, methylation, ubiquitination, biotinylation, alkylation, acetylation, glutamylation, glycylation, isoprenylation, lipoylation, phosphoantetheinylation, sulfation, citrullination, deamidation, isomerization, or a combination thereof.

### Claim 27 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said composition comprises at least one macromolecule involved in protein modification.

### Claim 28 (depends on 27)

The composition of claim 27, wherein said at least one macromolecule modifies a protein by phosphorylation, glycosylation, methylation, ubiquitination, biotinylation, alkylation, acetylation, glutamylation, glycylation, isoprenylation, lipoylation, phosphoantetheinyiation, sulfation, citrullination, deamidation, glycosyltransferase, glycosidase, transglycosidase or isomerization.

### Claim 29 (depends on 27)

The composition of claim 27, wherein said glycosylation is N- or O-glycosylation.

### Claim 30 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said composition comprises an extract that provides the necessary macromolecules that function in post-translational modification of a protein.

### Claim 31 (depends on 30)

The composition of claim 30, wherein said extract is from a eukaryotic or prokaryotic cell.

### Claim 32 (depends on 31)

The composition of claim 31, wherein said eukaryotic cell is a Chinese hamster ovary (CHO) cell.

### Claim 33 (depends on 1)

The compositions of any of claims 1, wherein said composition is capable of said protein manufacturing for at least about 1, 2, 3, 4, 5, 6 or 7 days.

### Claim 34 (depends on 1, 2, 3, 4)

The composition of any of claims 1 to 4, wherein said composition further comprises at least one nucleic acid molecule cross-linked to an agent that functions to stabilize said matrix.

### Claim 35 (depends on 34)

The composition of claim 34, wherein said agent is a nanoparticle.

### Claim 36 (depends on 34)

The composition of claim 34, wherein said agent is gold.
